vimarsana.com

Page 13 - ஆராய்ச்சியாளர்கள் இல் ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

China considers mixing COVID-19 vaccines to boost immunity

BEIJING    The poster was not the slickest marketing campaign, but it made its point: “Come get your eggs!!!” Every person above age 60 who got a COVID-19 vaccine at this community center in Beijing would be entitled to two boxes of free eggs. The deal was part of a nationwide push to raise vaccination rates in a country where successful containment of the pandemic has spurred complacency despite ample supplies of vaccine. Chinese authorities have set a target of vaccinating 40% of its population of 1.4 billion by June. As of April 14, nearly 180 million doses had been administered, according to health authorities, though the number of fully vaccinated people that represents is unknown.

Oxford study shows higher clotting risks from COVID than vaccines

© Getty Images Researchers at Oxford University said Thursday that the risk of developing rare blood clots is higher after becoming infected with COVID-19 than it is for people who have been vaccinated.  The findings come in a new study published by the university, which helped develop the AstraZeneca vaccine that has now come under scrutiny for potential links to a brain blood clot known as cerebral venous sinus thrombosis (CVST).  After comparing the number of CVST cases in the two weeks following a COVID-19 diagnosis and after the first dose of a vaccine, Oxford reports that the risk of developing the blood clots is as much as 10 times greater following a COVID-19 infection than it is after a vaccination. 

Risk of rare blood clots is higher after COVID-19 infection than after vaccination, UK study says

endIndex: (CNN) - Researchers at Oxford University have found the risk of a rare type of blood clot is low overall, but higher for people who have been infected with COVID-19 than among people who’ve had the three vaccines authorized in the UK – those made by AstraZeneca, Moderna and Pfizer. The study, made available in pre-print on Thursday on the Oxford website ahead of publication in a scientific journal, says the risk of cerebral venous thrombosis or CVT – also known as cerebral venous sinus thrombosis or CVST – following COVID-19 infection is around “100 times greater than normal and several times higher than it is post vaccination or following influenza,” across all age groups.

LIVE BLOG: R&D response to COVID-19 pandemic

LIVE BLOG: R&D response to COVID-19 pandemic
sciencebusiness.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencebusiness.net Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.